Glecaprevir and Pibrentasvir

CHEBI:CHEBI_751453

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
active_ingredient_strength
40 mg/1
dosage_form
TABLET, FILM COATED
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
labeler_name
Fournier Laboratories Ireland LTD
marketing_start_date
20170203
active_ingredient_name
PIBRENTASVIR
generic_name
Glecaprevir and Pibrentasvir
product_ndc
68543-2625
spl_id
7648cc24-8e8f-482e-8427-74f57f8a7f08
package_ndc
68543-2625-8
package_description
18000 TABLET, FILM COATED in 1 CONTAINER (68543-2625-8)
package_marketing_start_date
03-FEB-17
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class